Tyme Technologies Inc. (TYME)

[mcsharkey]

Got 2 of 3 Oncology Articles, both covering our mainline SM-88 Clinical PANC clinical trials. This is self-sponsored going to be reported on with Monday's shin dig. The second and third reviews with a Dr. Ocean. Evidently positive. Hanuman, you're a clinician. See what you can make out of these:)

Trials Will Change the Metastatic Pancreatic Cancer Landscape
CAROLINE SEYMOUR
Friday, October 16, 2020
https://www.oncnursingnews.com/web-exclusives/clinical-trials-will-change-the-metastatic-pancreatic-cancer-landscape

Less Tumor Texture Variability From Baseline May Be Linked With Better Outcomes in PDAC
January 7, 2021
Hayley Virgil
https://www.onclive.com/view/less-tumor-texture-variability-from-baseline-may-be-linked-with-better-outcomes-in-pdac